Australia markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
41.60+0.29 (+0.70%)
At close: 04:00PM EDT
41.60 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7798
Avg. Estimate-0.61-0.6-2.49-2.79
Low estimate-0.76-0.73-2.97-3.29
High estimate-0.49-0.38-1.4-2.18
Year ago EPS-0.67-0.63-2.67-2.49
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5598
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.67-0.65-0.63-0.59
Actual EPS-0.67-0.63-0.61-0.76
Difference00.020.02-0.17
Surprise %0.00%3.10%3.20%-28.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.61-0.6-2.49-2.79
7 days ago-0.61-0.6-2.49-2.79
30 days ago-0.61-0.6-2.49-2.79
60 days ago-0.59-0.59-2.63-2.83
90 days ago-0.59-0.59-2.56-2.73
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCEREIndustrySector(s)S&P 500
Current qtr.9.00%N/AN/AN/A
Next qtr.4.80%N/AN/AN/A
Current year6.70%N/AN/AN/A
Next year-12.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A